However, METTL14 was found to act as both the tumor suppressor and the oncogenic protein by collaborating with different m6A “reader” proteins in the context of diverse cancer types (Cui et al., 2017; Ma et al., 2017; Liu et al., 2018; Weng et al., 2018). The gene discussed is METTL14; the disease is neoplasm.